Sucampo 收购 Vtesse Inc.
April 04, 2017 13:46 ET
|
Sucampo Pharmaceuticals Inc
价值 2 亿美元的交易（先期付款） C1 型尼曼-匹克氏病（NPC-1）晚期计划多元临床产品 增加公司对有高度需求的专科疾病的专注 关注孤儿和儿科疾病 预计盈利将于 2019 年开始增加 Sucampo 和 Vtesse 的股东和投资者共同建立支持 NPC 疾病相关研究的基金会 公司将于今天美国东部时间上午 8:30 主持电话会议 马里兰州罗克维尔和盖瑟斯堡, April ...
Sucampo adquiere Vtesse Inc.
April 04, 2017 13:46 ET
|
Sucampo Pharmaceuticals Inc
La transacción está valuada en $200 millones por adelantado Diversifica el proceso de venta con el Programa de etapa avanzada para la enfermedad de Niemann-Pick tipo C1 (NPC-1) Aumenta la atención...
スキャンポ、ヴィテッセを買収
April 04, 2017 13:46 ET
|
Sucampo Pharmaceuticals Inc
取引価値は前払金額2億ドルニーマン･ピック病C1型 (NPC-1) の後期段階プログラムでパイプラインを多角化大きなアンメットニーズのある希少疾病に企業の焦点を絞る希少疾病および小児疾病への特化を活用2019年以降に収入が拡大される見込みスキャンポおよびヴィテッセの株主および投資者は、NPC疾病に関連する研究をサポートする基金を設立同社は本日午前8時30分 (東部夏時間)...
Sucampo Acquires Vtesse Inc.
April 03, 2017 06:30 ET
|
Sucampo Pharmaceuticals Inc
Transaction Valued at $200 Million Upfront Diversifies Pipeline with Late Stage Program in Niemann-Pick Disease Type C1 (NPC-1) Increases Company Focus on Specialized Diseases with High Unmet Need ...
Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 16th Annual Needham Healthcare Conference
March 28, 2017 16:01 ET
|
Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., March 28, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate...
Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the Oppenheimer 27th Annual Healthcare Conference
March 15, 2017 17:01 ET
|
Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., March 15, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will webcast its corporate...
Sucampo Reports Fourth Quarter and Full Year 2016 Financial Results
March 08, 2017 06:30 ET
|
Sucampo Pharmaceuticals Inc
Continued Revenue Growth Leads to Strong Income Growth Company Reiterates 2017 Guidance Company Announces Key Executive Transitions Company to Host Conference Call Today at 8:30 a.m. EST ...
Sucampo Announces Fourth Quarter and Full Year 2016 Earnings Call
February 23, 2017 16:02 ET
|
Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., Feb. 23, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (NASDAQ:SCMP), a global biopharmaceutical company, today announced that it will host its fourth quarter and...
Sucampo Pharmaceuticals Announces Webcast of Its Presentation at the 2017 Leerink Global Healthcare Conference
February 09, 2017 06:30 ET
|
Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., Feb. 09, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq:SCMP), a global biopharmaceutical company, today announced that it will participate in a fireside...
Sucampo Announces Pricing of $260.0 Million 3.25% Convertible Senior Notes due 2021
December 21, 2016 02:00 ET
|
Sucampo Pharmaceuticals Inc
ROCKVILLE, Md., Dec. 21, 2016 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (NASDAQ:SCMP), a global biopharmaceutical company, today announced the December 20, 2016 pricing of $260.0 million...